Anthony Adam Rosenberg
Chairman at OCULIS HOLDING AG
Net worth: 2 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Nadim Ahmed | M | 56 |
Cullinan Mica Corp.
 Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Part of Cullinan Therapeutics, Inc., Cullinan Mica Corp. is a private company that provides worldwide rights to CLN-619. The company is based in Cambridge, MA. The CEO of the company is Nadim Ahmed. | 3 years |
| Riad Sherif | M | 56 |
Oculis SA
 Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | 7 years |
| Kristen Laguerre | F | - |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 7 years |
| Steven Helwig | M | 51 | 9 years | |
| Patrick Baeuerle | M | 66 |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 9 years |
| Tim van Hauwermeiren | M | 52 | 16 years | |
| Thomas Ebeling | M | 65 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | 15 years |
| Jacquelyn Sumer | F | 46 | 2 years | |
| Lionel Carnot | M | 56 |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | 7 years |
| Martijn Kleijwegt | M | 69 | 1 years | |
| Sylvia Cheung | F | 50 | 4 years | |
| Beth Delgiacco | F | - | 6 years | |
| Christina Ackermann | F | 59 | 1 years | |
| Thorsteinn Loftsson | M | - |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | - |
| Pravin Dugel | M | 60 | 4 years | |
| Bill Winters | M | 62 | 11 years | |
| Chhaya Shah | F | 60 | 6 years | |
| James Daly | M | 63 | 6 years | |
| Bruce Mitlak | M | - | 8 years | |
| Devin Quinlan | M | - |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 6 years |
| Ana Cespedes | M | 51 | 2 years | |
| Jennifer Michaelson | M | 57 | 6 years | |
| Anne-Marie Martin | M | 52 | 2 years | |
| David Ryan | M | 57 | 2 years | |
| Steve Krognes | M | 56 | 1 years | |
| Camilla Sylvest | F | 52 | 2 years | |
| Nancy Andrews | M | 65 | 9 years | |
| Hans Jörg Reinhardt | M | 68 | 11 years | |
| Stephen Webster | M | 63 | 4 years | |
| Joseph deBethizy | M | 74 | 9 years | |
| Geraldine O'Keeffe | F | 58 | 1 years | |
| Peter K. M. Verhaeghe | M | 66 | 16 years | |
| Pamela Klein | M | 63 | 8 years | |
| Robert S. Abrams | M | - |
SiO2 Medical Products, Inc.
 SiO2 Medical Products, Inc. Medical SpecialtiesHealth Technology SiO2 Medical Products, Inc. manufactures pharmaceutical products. It offers vials, syringes, cartridges, microplates, blood tubes, and bioscience consumables. The company was founded by Robert Abrams in November 2011 and is headquartered in Auburn, AL. | 12 years |
| Peter A. Schwartzman | M | - | 4 years | |
| Charles Sawyers | M | 65 | 11 years | |
| Filip Borgions | M | - | 9 years | |
| Thomas Strungmann | M | - |
SiO2 Medical Products, Inc.
SiO2 Medical Products, Inc. Medical SpecialtiesHealth Technology SiO2 Medical Products, Inc. manufactures pharmaceutical products. It offers vials, syringes, cartridges, microplates, blood tubes, and bioscience consumables. The company was founded by Robert Abrams in November 2011 and is headquartered in Auburn, AL. | - |
| Vanessa Huang | F | - |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | - |
| Stephanie Torruella | F | - | 4 years | |
| Salvador Grausso | M | 49 | 4 years | |
| Ken Kelly | M | - |
SiO2 Medical Products, Inc.
SiO2 Medical Products, Inc. Medical SpecialtiesHealth Technology SiO2 Medical Products, Inc. manufactures pharmaceutical products. It offers vials, syringes, cartridges, microplates, blood tubes, and bioscience consumables. The company was founded by Robert Abrams in November 2011 and is headquartered in Auburn, AL. | - |
| Henry Skinner | M | 60 |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | - |
| Thierry Laugel | M | 57 |
Kurma Partners SA
 Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | 15 years |
| Melissa Simon | F | 42 |
SiO2 Medical Products, Inc.
SiO2 Medical Products, Inc. Medical SpecialtiesHealth Technology SiO2 Medical Products, Inc. manufactures pharmaceutical products. It offers vials, syringes, cartridges, microplates, blood tubes, and bioscience consumables. The company was founded by Robert Abrams in November 2011 and is headquartered in Auburn, AL. | - |
| Laurent Arthaud | M | 61 |
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | - |
| Jared Morris | M | - |
SiO2 Medical Products, Inc.
SiO2 Medical Products, Inc. Medical SpecialtiesHealth Technology SiO2 Medical Products, Inc. manufactures pharmaceutical products. It offers vials, syringes, cartridges, microplates, blood tubes, and bioscience consumables. The company was founded by Robert Abrams in November 2011 and is headquartered in Auburn, AL. | - |
| Jean-François Rivassou | M | - |
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | 3 years |
| Cole Ikkala | M | - | 4 years | |
| Jean-Marie Jacques Painvin | M | 72 |
SiO2 Medical Products, Inc.
SiO2 Medical Products, Inc. Medical SpecialtiesHealth Technology SiO2 Medical Products, Inc. manufactures pharmaceutical products. It offers vials, syringes, cartridges, microplates, blood tubes, and bioscience consumables. The company was founded by Robert Abrams in November 2011 and is headquartered in Auburn, AL. | - |
| Corinne Savill | M | 64 | 7 years | |
| Rémi Droller | M | 48 |
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | 14 years |
| Robert Hopfner | M | 51 |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | - |
| Robert J. Pangborn | M | - |
SiO2 Medical Products, Inc.
SiO2 Medical Products, Inc. Medical SpecialtiesHealth Technology SiO2 Medical Products, Inc. manufactures pharmaceutical products. It offers vials, syringes, cartridges, microplates, blood tubes, and bioscience consumables. The company was founded by Robert Abrams in November 2011 and is headquartered in Auburn, AL. | - |
| Briggs Morrison | M | 65 |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 9 years |
| Páll Jóhannesson | M | 44 | - | |
| John Belfance | M | - |
SiO2 Medical Products, Inc.
SiO2 Medical Products, Inc. Medical SpecialtiesHealth Technology SiO2 Medical Products, Inc. manufactures pharmaceutical products. It offers vials, syringes, cartridges, microplates, blood tubes, and bioscience consumables. The company was founded by Robert Abrams in November 2011 and is headquartered in Auburn, AL. | - |
| Peter Neubeck | M | - |
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | - |
| John S. Stein | M | 58 |
SiO2 Medical Products, Inc.
SiO2 Medical Products, Inc. Medical SpecialtiesHealth Technology SiO2 Medical Products, Inc. manufactures pharmaceutical products. It offers vials, syringes, cartridges, microplates, blood tubes, and bioscience consumables. The company was founded by Robert Abrams in November 2011 and is headquartered in Auburn, AL. | - |
| Ahmad Taha | M | - |
SiO2 Medical Products, Inc.
SiO2 Medical Products, Inc. Medical SpecialtiesHealth Technology SiO2 Medical Products, Inc. manufactures pharmaceutical products. It offers vials, syringes, cartridges, microplates, blood tubes, and bioscience consumables. The company was founded by Robert Abrams in November 2011 and is headquartered in Auburn, AL. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ansbert Gadicke | M | 66 | 11 years | |
| Daniel Vasella | M | 70 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | 17 years |
| Owen Hughes | M | 49 | 5 years | |
| Jose Carmona | M | 51 | 16 years | |
| Jean-Pierre Sommadossi | M | 68 | 12 years | |
| Daniel Dolan | M | 47 | 4 years | |
| Maria D. Stahl | F | 53 | 7 years | |
| Brian Harvey | M | 63 | 11 years | |
| James Chopas | M | 58 | 3 years | |
| Jesper Høiland | M | 63 | 3 years | |
| Eric Castaldi | M | 59 | 7 years | |
| Kurt Graves | M | 56 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | 18 years |
| Robert E. Ward | M | 66 | 4 years | |
| Meryl Zausner | F | 67 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | 8 years |
| Eric S. Hoffman | M | 54 | 3 years | |
| Brent Hatzis-Schoch | M | 59 | 4 years | |
| Averi Price | F | - | 6 years | |
| Wendelin Wiedeking | M | 72 | 11 years | |
| Rolf M. Zinkernagel | M | 80 | 15 years | |
| George Martin | M | 65 | 2 years | |
| Elhan Webb | F | - | - | |
| William Ludlam | M | 59 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | 3 years |
| Christi L. Shaw | F | 57 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | 6 years |
| Herve Hoppenot | M | 64 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | 8 years |
| Shinichiro Fuse | M | - |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 5 years |
| Kathleen Goetz | - | - |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | 12 years |
| Charles W. Cramb | M | 77 | 9 years | |
| Catherine Friedman | F | 63 | 7 years | |
| Gary Hattersley | M | 57 | 15 years | |
| David Epstein | M | 62 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | 6 years |
| Werner Lanthaler | M | 56 | 9 years | |
| Martin C. Münchbach | M | 54 | 4 years | |
| Jean-Pierre Garnier | M | 75 | 7 years | |
| Usman Azam | M | 55 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | - |
| Lisa M. Goldman | F | - |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | - |
| Paulo Costa | M | 73 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | 6 years |
| Alan Auerbach | M | 54 | 6 years | |
| Sean Murphy | M | 71 | 2 years | |
| Tamar Howson | F | 75 | 8 years | |
| Nicholas McGrath | M | - |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 64 | 64.00% |
| Switzerland | 21 | 21.00% |
| Netherlands | 12 | 12.00% |
| France | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Anthony Adam Rosenberg
- Personal Network
